Interestingly, the patient achieving the longest PFS had a lower methylation value compared to others; in this regard, the results may be explained by the fact that tumor MGMT expression was negative, other than that the patient was less pretreated than the others and received a combination regimen (TEMIRI). This evidence concerns the gene MGMT and neoplasm.